|
顯示項目 226571-226580 / 2348674 (共234868頁)
<< < 22653 22654 22655 22656 22657 22658 22659 22660 22661 22662 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2011 |
Biomarker Analyses and Final Overall Survival Results from a Phase Iii, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/ Paclitaxel in Clinically Selected Patients with Advanced Non-Small-Cell Lung Cancer in Asia (Ipass)
|
楊志新; 趙祖怡; YANG, CHIH-HSIN; CHAO, TSU-YI |
| 臺大學術典藏 |
2020-05-26T09:27:11Z |
Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non - small-cell lung cancer in Asia (IPASS)
|
Fukuoka M;Wu Y.-L;Thongprasert S;Sunpaweravong P;Leong S.-S;Sriuranpong V;Chao T.-Y;Nakagawa K;Chu D.-T;Saijo N;Duffield E.L;Rukazenkov Y;Speake G;Jiang H;Armour A.A;To K.-F;Chih-Hsin Yang;Mok T.S.K.; Fukuoka M; Wu Y.-L; Thongprasert S; Sunpaweravong P; Leong S.-S; Sriuranpong V; Chao T.-Y; Nakagawa K; Chu D.-T; Saijo N; Duffield E.L; Rukazenkov Y; Speake G; Jiang H; Armour A.A; To K.-F; CHIH-HSIN YANG; Mok T.S.K. |
| 國立臺灣大學 |
2012 |
BIOMARKER ANALYSES AND OVERALL SURVIVAL (OS) FROM THE RANDOMIZED, PLACEBO-CONTROLLED, PHASE 3, FASTACT-2 STUDY OF INTERCALATED ERLOTINIB WITH FIRST-LINE CHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
|
Mok, T. S. K.; Lee, J. S.; Zhang, L.; Yu, C.; Thongprasert, S.; Ladrera, G. E. I.; Srimuninnimit, V.; Truman, M. I.; Klughammer, B.; Wu, Y. |
| 國立臺灣大學 |
2009 |
Biomarker Analyses from a Phase Iii, Randomized, Open-Label, First-Line Study of Gefitinib (G) Versus Carboplatin/Paclitaxel (C/P) in Clinically Selected Patients (Pts) with Advanced Non-Small Cell Lung Cancer (Nsclc) in Asia (Ipass)
|
楊志新; YANG, CHIH-HSIN |
| 臺大學術典藏 |
2020-05-26T09:27:00Z |
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of Advanced Non-Small-Cell Lung Cancer (ATLAS)
|
Kabbinavar F;Fehrenbacher L;Hainsworth J;Kasubhai S;Kressel B;Marsland T;Patel T;Rubin M;White L;Chih-Hsin Yang;Klughammer B;Colburn D;Miller V;Johnson B.E.; Kabbinavar F; Fehrenbacher L; Hainsworth J; Kasubhai S; Kressel B; Marsland T; Patel T; Rubin M; White L; CHIH-HSIN YANG; Klughammer B; Colburn D; Miller V; Johnson B.E. |
| 國立臺灣大學 |
2011 |
Biomarker Analysis in Bo21015, a Phase Ii Randomised Study of First-Line Bevacizumab (Bev) Combined with Carboplatin-Gemcitabine (Cg) or Carboplatin-Paclitaxel (Cp) in Patients (Pts) with Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer (Nscl
|
余忠仁; YU, CHONG-JEN |
| 國立成功大學 |
2011-05-03 |
Biomarker and method for evaluating risk of proliferation, invasion, or metastasis of cancer
|
Sun, Sunny H.; Chen, Jia-Shing |
| 國立成功大學 |
2017 |
Biomarker assessments of sources and environmental implications of organic matter in sediments from potential cold seep areas of the northeastern South China Sea
|
Ding, L.;Zhao, M.;Yu, M.;Li, Li L.;Huang, C.-Y. |
| 臺大學術典藏 |
2021-11-22T05:25:27Z |
Biomarker discovery in highly invasive lung cancer cell through proteomics approaches
|
Kuo, Chin-Ho; Lin, Meng-Wei; Hsu, Yu-Wei; Chou, Hsiu-Chuan; Lin, Li-Hsun; Law, Ching-Hsuan; Lin, Yi-Chieh; Hu, Ren-Yu; WEN-HUNG KUO; Ko, Mei-Lan; Chang, Shing-Jyh; Lee, Ying-Ray; Chan, Hong-Lin |
| 國立臺灣大學 |
2007-10 |
Biomarker distributions as maturity indicators in coals, coaly shales and shales from Taiwan
|
Shen, J.C.; Huang, W.L. |
顯示項目 226571-226580 / 2348674 (共234868頁)
<< < 22653 22654 22655 22656 22657 22658 22659 22660 22661 22662 > >>
每頁顯示[10|25|50]項目
|
